GeneSwitch™ 哺乳动物表达试剂盒,全套试剂盒
Product Image
Invitrogen™

GeneSwitch™ 哺乳动物表达试剂盒,全套试剂盒

Switch-On Expression from the Lowest Basal LevelsThe GeneSwitch™ System for inducible mammalian expression is ideal for experiments that require the了解更多信息
Have Questions?
货号数量
K106001
又称 K1060-01
1 kit
货号 K106001
又称 K1060-01
价格(CNY)
28,207.35
飞享价
Ends: 31-Dec-2025
33,683.00
共减 5,475.65 (16%)
Each
添加至购物车
数量:
1 kit
价格(CNY)
28,207.35
飞享价
Ends: 31-Dec-2025
33,683.00
共减 5,475.65 (16%)
Each
添加至购物车
Switch-On Expression from the Lowest Basal Levels
The GeneSwitch™ System for inducible mammalian expression is ideal for experiments that require the absolute lowest uninduced expression levels. The expression vector pGene/V5-His provides a minimal promoter, GAL4-E1b, consisting of the binding sites for the yeast Gal4 DNA binding protein followed by the TATA sequence from the Adenovirus E1b promoter. Without additional factors, the GAL4-E1b promoter is transcriptionally silent.

To activate transcription from the GAL4-E1b promoter, the GeneSwitch™ regulatory protein is expressed from a minimal TK promoter on the pSwitch vector. The GeneSwitch™ protein has three functional domains:

• Gal4 DNA Binding Domain (Gal4-DBD) to bind the regulatory protein to the GAL4-E1b promoter
• Truncated human Progesterone Receptor Ligand Binding Domain (hPR-LBD) that undergoes a conformational change when it binds the progesterone antagonist, mifepristone
• Transcription activation domain from the NFØB transcription factor p65 (p65AD) to activate transcription from the silent GAL4-E1b promoter

In the absence of mifepristone, the conformation of the hPR-LBD region prevents the GeneSwitch™ regulatory protein from activating transcription from the GAL4-E1b promoter. When mifepristone is added and binds the hPR-LBD region, the GeneSwitch™ regulatory protein assumes a conformation that permits it to stimulate transcription from the GAL4-E1b promoter (Figures 1 and 2).

Induction of the GeneSwitch™ System leads to activation of the gene of interest on the vector pGene/V5-His. In addition, four Gal4 binding sites upstream of the minimal HSV TK promoter on pSwitch can bind the pSwitch regulatory protein. Therefore, adding mifepristone up-regulates production of the regulatory protein (Figure 1). The increased levels of the GeneSwitch™ regulatory protein result in induction of the gene of interest from pGene/V5-His to levels that can approach those of viral promoters.

The GeneSwitch™ Kit offers exceptionally low uninduced and high induced expression levels in mammalian cells. The system provides the expression vector pGene/V5-His with the minimal, synthetic GAL4-E1b promoter that is transcriptionally silent until activated. The GeneSwitch™ regulatory protein binds the GAL4-E1b promoter to activate transcription upon the addition of mifepristone. In addition, the GeneSwitch™ protein upregulates its own expression, leading to amplified expression of the gene of interest from pGene/V5-His. pGene/V5-His offers several features that facilitate expression analysis and purification of recombinant proteins in mammalian cells:

• C-terminal V5 epitope tag for detection with Anti-V5 Antibodies
• C-terminal polyhistidine (6xHis) tag for rapid purification with nickel-chelating resin and detection with Anti-His(C-term) Antibodies
• The Zeocin™ resistance gene for effective selection in both mammalian cells and E. coli
仅供科研使用。不可用于诊断程序。
规格
构成或诱导系统诱导
输送类型转染
适用于(应用)调节表达
诱导剂米非司酮
产品类型哺乳动物表达试剂盒
数量1 kit
选择试剂(真核生物)Zeocin™
载体pGene
克隆方法限制性内切酶/MCS
产品线GeneSwitch™
促进剂E1b (GAL4-E1b)
蛋白标记His 标签 (6x)、V5 抗原决定簇标签, V5 Epitope Tag
Unit SizeEach
内容与储存
GeneSwitch™ 系统核心试剂盒包括各 20 µg 以下载体:pGene/V5-His(A、B 和 C)、表达对照载体 pGene/V5-His/lacZ 和 pSwitch 载体。试剂盒还包括正向和反向测序引物和 100 µg 诱导剂米非司酮。GeneSwitch™ 全套试剂盒包括含 1 g 潮霉素和 1 g Zeocin™(大量节省)的核心试剂盒。潮霉素应在 +4°C 下储存,Zeocin™ 应在 -20°C 下储存。Zeocin™ 应避光保存。妥善储存时,所有试剂均可稳定储存 6 个月。

常见问题解答 (FAQ)

你们是否提供GeneSwitch细胞系?

抱歉,所有的GeneSwitch细胞系均已停产。

何为GeneSwitch蛋白的关键特性?

GeneSwitch蛋白包含了源自不同转录因子的功能域,可作为配体依赖的转录因子行使功能,来激活目的基因或自身内源基因的表达。GeneSwitch能够表现出如下属性:

•由于GAL4 DBD来源于酵母蛋白,GeneSwitch蛋白不会对内源基因造成影响,而只会激活GAL4 UAS元件所控制那些基因的转录过程(即目的基因和调节性融合基因)。
•GAL4 DBD能够以同源二聚体的形式结合独立的17核苷酸GAL-4结合位点。pGene/V5-His与pSwitch质粒中分别包含了6个和4个拷贝的GAL4结合位点,但尚不清楚是否所有这些GAL4-结合位点在任意时间都处于占用状态。
•截短型的hPR-LBD的C-端截去了19个氨基酸,从而失去了与孕酮,其他内源的甾族荷尔蒙及其他孕酮激动剂的结合能力,但仍能够与米非司酮进行高亲和力的结合。
•p65 AD是一个强力的转录激动剂且来源于人体蛋白,因此能够最大程度的减少可能存在的毒性或病毒转录激活域相关的多效影响。

为何在T-REx和GeneSwitch系统中推荐使用连续转染而非共转染?

当执行共转染时,用户无法在稳转细胞系中同时完成功能性TetR或GeneSwitch蛋白的双重测试。另一方面,如果执行连续转染,用户就可对所生成的T-REx或GeneSwitch细胞系进行功能性测试,他们可将LacZ对照表达质粒瞬转进入细胞,并挑取那些在诱导剂缺乏条件下表达LacZ的本底水平最低,而在含诱导剂条件下LacZ表达水平最高的克隆。之后可对这一克隆进行扩增,并按需用于T-REx或GeneSwitch表达载体的转染实验。

GeneSwitch系统超越T-REx系统的主要优势有哪些?其主要劣势有哪些?

使用GeneSwitch系统能够确保目的基因处于极低的基础表达水平,而T-REx系统可能会有少量渗漏表达,因为FBS中不可避免的存在着一些四环素。GeneSwitch系统的诱导表达水平可能甚至高于CMV启动子。GeneSwitch系统的劣势在于,尽管该系统能够在转基因条件下以优异的性能工作,但在培养系统中关闭表达的操作不是很容易实现。而另一方面,T-REx系统可通过加入和去除诱导剂来切换开关状态。

我对能够调控目的基因表达的哺乳动物表达系统很感兴趣。我看到你们为此类应用准备了多种系统。你们能描述一下每一系统的主要特性么?

我们提供三类独特的哺乳动物表达系统来帮助用户实现目的基因可诱导/调控性的表达。

•T-REx系统
•Flp-In T-REx系统
•GeneSwitch系统

请参见下表中的比较结果:

系统 --基础表达水平--诱导表达水平--表达最大化的响应时间--转基因应用
T-REx系统--低--最高--高--合适
Flp-In T-REx系统--较低--高--24-48小时--合适
GeneSwitch系统--最低--高--24-48小时--合适